Saturday, November 14, 2026

Technology & Economy

3 articles

Graphic Design Job Postings Drop 57% Worldwide as AI Displaces Creative Work

Graphic Design Job Postings Drop 57% Worldwide as AI Displaces Creative Work

Graphic design job postings fell 57% globally over the past year, with product design roles down 18%. IDEO, the consultancy that shaped design thinking worldwide, saw revenue collapse from $300 million to under $100 million. AI tools including Midjourney, Adobe Firefly, and Figma AI are automating the volume work that once funded design firms across every major market.

LM Salvado•
One Taiwanese Foundry Stands Between Broadcom and $100 Billion in AI Revenue

One Taiwanese Foundry Stands Between Broadcom and $100 Billion in AI Revenue

Broadcom's CEO has forecast $100 billion or more in annual custom AI chip revenue by 2027 — all of it dependent on TSMC's Taiwan fabs. No rival foundry in South Korea, the US, or Europe matches TSMC's capability at scale. A Taiwan Strait disruption would halt that pipeline with no short-term alternative for Broadcom or its global cloud customers.

LM Salvado•
AI's Voracious Power Appetite Is Redrawing the Global Chip and Energy Map

AI's Voracious Power Appetite Is Redrawing the Global Chip and Energy Map

The artificial intelligence boom is generating an unprecedented demand for electricity that is reshaping semiconductor markets, data center infrastructure, and energy grids worldwide. Nations and corporations alike are racing to secure the power and silicon needed to compete in the AI era, concentrating capital in a handful of strategic chokepoints. The ripple effects extend from U.S. monetary policy to European energy planning and Asian chip supply chains.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,580 source documents archived
Query this data → isubstrate.com